Cardiol Therapeutics Inc.
Last · TorontoC$1.60-0.11 (-6.43%)close · yahoo · 16h ago
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume158.3Ksession
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.08
Est. revenue
0
Earnings transcripts
- Issuer webcast
Cardiol Therapeutics Presentation of Phase II ARCHER Trial Results
Cardiol Therapeutics Inc.
- Issuer webcast
TD Cowen 45th Annual Health Care Conference
Cardiol Therapeutics Inc.
- Issuer webcast
Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Cardiol Therapeutics Inc.
- Issuer webcast
Canaccord Genuity's KOL Event Featuring Paul Cremer, M.D, the MAVERIC Phase III trial Principal Investigator and MAVERIC Program Steering Committee Member
Cardiol Therapeutics Inc.